Ruxience is biologic therapy that is indicated for treating
- moderately to severely active rheumatoid arthritis (RA) and currently taking methotrexate
- other autoimmune diseases
- multiple sclerosis
- lupus
- chronic inflammatory demyelinating polyneuropathy
Ruxience (rituximab-pvvr) is an FDA-approved biosimilar to Rituxan that is indicated to treat rheumatoid arthritis in adults.
Patients choose Red Bank Infusion Center
to have their Ruxience therapy because
- of our flexible, worry-free scheduling, with evening and weekend appointments available
- our all-private infusion suites, with the latest COVID safety standards in place for your protection
- equipped with medical-grade, leather recliners, with chairs and amenities for your guests
- including large, flat screen TVs, free WiFi and entertainment channels for your viewing pleasure
- and our friendly, helpful clinical staff providing personalized service

Want to move to
Red Bank Infusion Center?
We make it simple and convenient for you to start your infusion care with us.